Sound Pharmaceuticals (SPI-5557 & SPI-1005)

@Ela Stefan, all we know from that study is it reduced/reversed the damage from NIHL in rodents 3 months after trauma. That's interesting as that is towards the chronic end of things. That being said, rodents often do not translate to human findings. Still interesting at this stage!

 

Are there any news of SPI-5557? It looks like it has not made any progress.

EDIT:

This is an interesting read retrospectively because the timetable was so optimistic.

It shows how theory and reality can differ from each other. I won't blame Sound Pharmaceuticals for that, I'm sure they are doing their best in this complex field.

Wayback Machine (archive.org)